Clinical Dermatology
FDA Approves Dupilumab for Chronic Spontaneous Urticaria: A New Era in Targeted Therapy
Dermatologic care is in the process of a significant advancement
May 8, 2025
Dermatologic care is in the process of a significant advancement
A new study published in the Journal of Investigative Dermatology
Medical procedures are inherently unpredictable, meaning that even in the
Biologics that inhibit the pro-inflammatory cytokine IL-23 have long been
As headlines report the recent revelation of benzene, a known
Monumental regulatory approvals are taking dermatologic care to new levels
Here is a brief recap of some of the most notable advances and the U.S. Food and Drug Administration (FDA) approvals in 2022.
It is widely accepted and recognized that psychodermatologic issues are commonly encountered in dermatological practices.
Dermatologic care is in the process of a significant advancement
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2025, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
